Try our beta test site
209 studies found for:    Open Studies | "Psoriasis"
Show Display Options
Rank Status Study
21 Recruiting Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis
Condition: Psoriasis
Interventions: Drug: 0.5% Icotinib hydrochloride cream;   Drug: 1.0% Icotinib hydrochloride cream;   Drug: 2.0% Icotinib hydrochloride cream;   Drug: 4.0% Icotinib hydrochloride cream;   Drug: Placebo
22 Recruiting Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients
Condition: Psoriasis
Interventions: Drug: 1% icotinib hydrochloride cream;   Drug: 2% icotinib hydrochloride cream;   Drug: Placebo
23 Recruiting An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis
Condition: Psoriasis
Interventions: Drug: CNTO 1959 50 mg;   Drug: CTNO 1959 100 mg;   Drug: Placebo 50 mg;   Drug: Placebo 100 mg
24 Recruiting A Registry of Patients With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Intervention:
25 Recruiting Spanish Registry of Systemic Treatments in Psoriasis
Condition: Psoriasis
Intervention:
26 Recruiting Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Secukinumab;   Drug: Ustekinumab
27 Not yet recruiting Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis
Condition: Psoriasis
Intervention: Biological: FURESTEM-CD Inj.
28 Recruiting Observational Study of Apremilast in Patients With Psoriasis in The Netherlands
Condition: Psoriasis
Intervention:
29 Recruiting Oral Psoriasis Treatment Adherence and Intervention Study
Condition: Psoriasis
Intervention: Behavioral: Internet Survey
30 Recruiting A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: Apremilast
31 Recruiting A Study of Otezla® in Patients With Plaque Psoriasis Under Routine Conditions
Condition: Psoriasis
Intervention:
32 Recruiting Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis
Condition: Chronic Plaque Psoriasis
Interventions: Drug: Bimekizumab;   Other: Placebo
33 Recruiting Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis.
Condition: Chronic Plaque Psoriasis
Interventions: Drug: Bimekizumab;   Other: Placebo
34 Recruiting A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice
Condition: Psoriasis
Intervention: Other: Patient questionnaire
35 Recruiting Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis
Condition: Chronic Plaque Psoriasis
Interventions: Drug: Bimekizumab;   Other: Placebo
36 Not yet recruiting Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Interventions: Biological: BCD-057;   Biological: Humira®
37 Not yet recruiting Proton Pump Inhibitors Use in Patients With Psoriasis
Condition: Psoriasis
Interventions: Drug: esomeprazole;   Drug: desonide
38 Recruiting Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients
Condition: Psoriasis
Intervention:
39 Recruiting A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Subjects and Patients With Plaque Psoriasis
Condition: Psoriasis
Interventions: Biological: GSK2831781;   Biological: Placebo
40 Recruiting Immunologic Response to Secukinumab in Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: Secukinumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.